Unique Public Status As one of the few publicly operated, FDA-licensed vaccine manufacturing facilities, MassBiologics offers a unique partnership opportunity for government agencies, public health organizations, and nonprofits seeking reliable, compliance-driven biologic production solutions.

Potential Government Funding Given its status as a state-operated entity with a long-standing public health mission, MassBiologics may be eligible for government grants, public funding programs, and partnerships focused on vaccine development and biotechnological innovation.

Vaccine Development Focus Specializing in vaccines and biologic products, the company presents opportunities to collaborate on infectious disease prevention, pandemic preparedness, and supply chain resilience for public health initiatives.

Mid-sized Growth Potential With approximately 51 to 200 employees and revenue between 50 million and 100 million dollars, MassBiologics is positioned as a growth-stage organization open to technological collaborations, supply chain enhancements, and advanced manufacturing solutions.

Strategic Location Advantage Located in Boston with facilities in Fall River, the company's geographical position offers access to a robust biotech ecosystem, academic collaboration opportunities, and governmental partnerships in Massachusetts and beyond.